Oncology Based In-Vivo CRO Market Share

Statistics for the 2023 & 2024 Oncology Based In-Vivo CRO market share, created by Mordor Intelligence™ Industry Reports. Oncology Based In-Vivo CRO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Oncology Based In-Vivo CRO Industry

The oncology-based In-Vivo CRO market is moderately competitive and consists of several major players. In terms of market share, few of the major players have been currently dominating the market. And some prominent players have been vigorously making acquisitions and joint ventures with other companies to consolidate their market positions worldwide. Some companies currently dominating the market are Crown Bioscience Inc., Charles River Laboratories Inc., ICON PLC, Taconic Biosciences Inc., Covance Inc., Eurofins Scientific, EVOTEC, The Jackson Laboratory, Wuxi AppTec. and MI Bioresearch Inc.

Oncology Based In-Vivo CRO Market Leaders

  1. Crown Bioscience Inc.

  2. Charles River Laboratories, Inc.

  3. ICON plc

  4. Taconic Biosciences, Inc.

  5. Covance Inc.

*Disclaimer: Major Players sorted in no particular order

Oncology Based In-Vivo CRO Market Concentration

Oncology Based In-Vivo CRO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)